Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 174 entries
Sorted by: Best Match Show Resources per page
Prognostic Value of IL-10 and Its Relationship with Disease Stage in Iranian Patients with Multiple Myeloma.

Asian Pacific journal of cancer prevention : APJCP

Shekarriz R, Janbabaei G, Abedian Kenari S.
PMID: 29373876
Asian Pac J Cancer Prev. 2018 Jan 27;19(1):27-32. doi: 10.22034/APJCP.2018.19.1.27.

Background: Several studies have demonstrated roles of interleukins in the pathogenesis of multiple myeloma (MM). Objective: Here we considered correlations among serum levels of IL-10, stage of disease and clinical laboratory disease markers in Iranian MM patients to investigate...

Cite
Shekarriz R, Janbabaei G, Abedian Kenari S. Prognostic Value of IL-10 and Its Relationship with Disease Stage in Iranian Patients with Multiple Myeloma. Asian Pac J Cancer Prev. 2018;19(1):27-32doi: 10.22034/APJCP.2018.19.1.27.
Shekarriz, R., Janbabaei, G., & Abedian Kenari, S. (2018). Prognostic Value of IL-10 and Its Relationship with Disease Stage in Iranian Patients with Multiple Myeloma. Asian Pacific journal of cancer prevention : APJCP, 19(1), 27-32. https://doi.org/10.22034/APJCP.2018.19.1.27
Shekarriz, Ramin, et al. "Prognostic Value of IL-10 and Its Relationship with Disease Stage in Iranian Patients with Multiple Myeloma." Asian Pacific journal of cancer prevention : APJCP vol. 19,1 (2018): 27-32. doi: https://doi.org/10.22034/APJCP.2018.19.1.27
Shekarriz R, Janbabaei G, Abedian Kenari S. Prognostic Value of IL-10 and Its Relationship with Disease Stage in Iranian Patients with Multiple Myeloma. Asian Pac J Cancer Prev. 2018 Jan 27;19(1):27-32. doi: 10.22034/APJCP.2018.19.1.27. PMID: 29373876; PMCID: PMC5844629.
Copy Download .nbib Format: NLM
Beta-2 microglobulin clearance in high-flux dialysis and convective dialysis modalities: a meta-analysis of published studies.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Roumelioti ME, Trietley G, Nolin TD, Ng YH, Xu Z, Alaini A, Figueroa R, Unruh ML, Argyropoulos CP.
PMID: 29329421
Nephrol Dial Transplant. 2018 Mar 01;33(3):542. doi: 10.1093/ndt/gfx373.

No abstract available.

Cite
Roumelioti ME, Trietley G, Nolin TD, et al. Beta-2 microglobulin clearance in high-flux dialysis and convective dialysis modalities: a meta-analysis of published studies. Nephrol Dial Transplant. 2018;33(3):542doi: 10.1093/ndt/gfx373.
Roumelioti, M. E., Trietley, G., Nolin, T. D., Ng, Y. H., Xu, Z., Alaini, A., Figueroa, R., Unruh, M. L., & Argyropoulos, C. P. (2018). Beta-2 microglobulin clearance in high-flux dialysis and convective dialysis modalities: a meta-analysis of published studies. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 33(3), 542. https://doi.org/10.1093/ndt/gfx373
Roumelioti, Maria-Eleni, et al. "Beta-2 microglobulin clearance in high-flux dialysis and convective dialysis modalities: a meta-analysis of published studies." Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association vol. 33,3 (2018): 542. doi: https://doi.org/10.1093/ndt/gfx373
Roumelioti ME, Trietley G, Nolin TD, Ng YH, Xu Z, Alaini A, Figueroa R, Unruh ML, Argyropoulos CP. Beta-2 microglobulin clearance in high-flux dialysis and convective dialysis modalities: a meta-analysis of published studies. Nephrol Dial Transplant. 2018 Mar 01;33(3):542. doi: 10.1093/ndt/gfx373. PMID: 29329421.
Copy Download .nbib Format: NLM
Early Predictors of Renal Dysfunction in Pediatric Patients with Sickle Cell Disease.

Indian journal of nephrology

El-Gamasy MA, El-Naghy WS.
PMID: 30814790
Indian J Nephrol. 2019 Jan-Feb;29(1):28-33. doi: 10.4103/ijn.IJN_40_18.

Sickle cell disease (SCD) is a hereditary hemoglobinopathy characterized by abnormal hemoglobin production which leads to hemolytic anemia and intermittent occlusion of small blood vessels, which further leads to tissue ischemia, chronic organ damage, and organ dysfunction including urinary...

Cite
El-Gamasy MA, El-Naghy WS. Early Predictors of Renal Dysfunction in Pediatric Patients with Sickle Cell Disease. Indian J Nephrol. 2019;29(1):28-33doi: 10.4103/ijn.IJN_40_18.
El-Gamasy, M. A., & El-Naghy, W. S. (2019). Early Predictors of Renal Dysfunction in Pediatric Patients with Sickle Cell Disease. Indian journal of nephrology, 29(1), 28-33. https://doi.org/10.4103/ijn.IJN_40_18
El-Gamasy, Mohamed Abdelaziz, and El-Naghy, Wageh S. "Early Predictors of Renal Dysfunction in Pediatric Patients with Sickle Cell Disease." Indian journal of nephrology vol. 29,1 (2019): 28-33. doi: https://doi.org/10.4103/ijn.IJN_40_18
El-Gamasy MA, El-Naghy WS. Early Predictors of Renal Dysfunction in Pediatric Patients with Sickle Cell Disease. Indian J Nephrol. 2019 Jan-Feb;29(1):28-33. doi: 10.4103/ijn.IJN_40_18. PMID: 30814790; PMCID: PMC6375016.
Copy Download .nbib Format: NLM
The Effect of Antenatal Steroid Therapy on Early Inflammation Markers and Leukocyte Counts in Premature Infants.

Fetal and pediatric pathology

Beser Ozmen E, Kadioglu Simsek G, Ceran B, Canpolat FE, Kanmaz Kutman HG.
PMID: 32677483
Fetal Pediatr Pathol. 2020 Jul 17;1-6. doi: 10.1080/15513815.2020.1792014. Epub 2020 Jul 17.

OBJECTIVE: We investigated the effect of antenatal steroid therapy(AST) on white blood cell (WBC) and neutrophil counts and the inflammatory markers C-reactive protein(CRP), interleukin 6(IL-6), interleukin 10(IL-10), and beta-2 microglobulin(ß2M) in preterm infants.RESULTS: Of these, 45.2% (n = 77)...

Cite
Beser Ozmen E, Kadioglu Simsek G, Ceran B, et al. The Effect of Antenatal Steroid Therapy on Early Inflammation Markers and Leukocyte Counts in Premature Infants. Fetal Pediatr Pathol. 2020;1-6doi: 10.1080/15513815.2020.1792014.
Beser Ozmen, E., Kadioglu Simsek, G., Ceran, B., Canpolat, F. E., & Kanmaz Kutman, H. G. (2020). The Effect of Antenatal Steroid Therapy on Early Inflammation Markers and Leukocyte Counts in Premature Infants. Fetal and pediatric pathology, 1-6. https://doi.org/10.1080/15513815.2020.1792014
Beser Ozmen, Esra, et al. "The Effect of Antenatal Steroid Therapy on Early Inflammation Markers and Leukocyte Counts in Premature Infants." Fetal and pediatric pathology vol. (2020): 1-6. doi: https://doi.org/10.1080/15513815.2020.1792014
Beser Ozmen E, Kadioglu Simsek G, Ceran B, Canpolat FE, Kanmaz Kutman HG. The Effect of Antenatal Steroid Therapy on Early Inflammation Markers and Leukocyte Counts in Premature Infants. Fetal Pediatr Pathol. 2020 Jul 17;1-6. doi: 10.1080/15513815.2020.1792014. Epub 2020 Jul 17. PMID: 32677483.
Copy Download .nbib Format: NLM
Kidney tubule health scores and their associations with incident CKD in women living with HIV.

HIV medicine

Ascher SB, Scherzer R, Estrella MM, Muiru AN, Jotwani VK, Grunfeld C, Shigenaga J, Spaulding KA, Ng DK, Gustafson D, Spence AB, Sharma A, Cohen MH, Parikh CR, Ix JH, Shlipak MG.
PMID: 33751761
HIV Med. 2021 Aug;22(7):527-537. doi: 10.1111/hiv.13081. Epub 2021 Mar 09.

OBJECTIVES: Individual kidney tubule biomarkers are associated with chronic kidney disease (CKD) risk in people living with HIV (PLWH). Whether a combination of kidney biomarkers can be integrated into informative summary scores for PLWH is unknown.METHODS: We measured eight...

Cite
Ascher SB, Scherzer R, Estrella MM, et al. Kidney tubule health scores and their associations with incident CKD in women living with HIV. HIV Med. 2021;22(7):527-537doi: 10.1111/hiv.13081.
Ascher, S. B., Scherzer, R., Estrella, M. M., Muiru, A. N., Jotwani, V. K., Grunfeld, C., Shigenaga, J., Spaulding, K. A., Ng, D. K., Gustafson, D., Spence, A. B., Sharma, A., Cohen, M. H., Parikh, C. R., Ix, J. H., & Shlipak, M. G. (2021). Kidney tubule health scores and their associations with incident CKD in women living with HIV. HIV medicine, 22(7), 527-537. https://doi.org/10.1111/hiv.13081
Ascher, S B, et al. "Kidney tubule health scores and their associations with incident CKD in women living with HIV." HIV medicine vol. 22,7 (2021): 527-537. doi: https://doi.org/10.1111/hiv.13081
Ascher SB, Scherzer R, Estrella MM, Muiru AN, Jotwani VK, Grunfeld C, Shigenaga J, Spaulding KA, Ng DK, Gustafson D, Spence AB, Sharma A, Cohen MH, Parikh CR, Ix JH, Shlipak MG. Kidney tubule health scores and their associations with incident CKD in women living with HIV. HIV Med. 2021 Aug;22(7):527-537. doi: 10.1111/hiv.13081. Epub 2021 Mar 09. PMID: 33751761.
Copy Download .nbib Format: NLM
Identification and evaluation of an appropriate housekeeping gene for real time gene profiling of hepatocellular carcinoma cells cultured in three dimensional scaffold.

Molecular biology reports

Badekila AK, Rai P, Kini S.
PMID: 34665400
Mol Biol Rep. 2021 Oct 19; doi: 10.1007/s11033-021-06830-y. Epub 2021 Oct 19.

BACKGROUND: Assessing an optimal reference gene as an internal control for target gene normalization is important during quantitative real time polymerase chain reaction (RT-qPCR) of three dimensional (3D) cell culture. Especially, gene profiling of cancer cells under a complex...

Cite
Badekila AK, Rai P, Kini S. Identification and evaluation of an appropriate housekeeping gene for real time gene profiling of hepatocellular carcinoma cells cultured in three dimensional scaffold. Mol Biol Rep. 2021;doi: 10.1007/s11033-021-06830-y.
Badekila, A. K., Rai, P., & Kini, S. (2021). Identification and evaluation of an appropriate housekeeping gene for real time gene profiling of hepatocellular carcinoma cells cultured in three dimensional scaffold. Molecular biology reports, . https://doi.org/10.1007/s11033-021-06830-y
Badekila, Anjana Kaveri, et al. "Identification and evaluation of an appropriate housekeeping gene for real time gene profiling of hepatocellular carcinoma cells cultured in three dimensional scaffold." Molecular biology reports vol. (2021). doi: https://doi.org/10.1007/s11033-021-06830-y
Badekila AK, Rai P, Kini S. Identification and evaluation of an appropriate housekeeping gene for real time gene profiling of hepatocellular carcinoma cells cultured in three dimensional scaffold. Mol Biol Rep. 2021 Oct 19; doi: 10.1007/s11033-021-06830-y. Epub 2021 Oct 19. PMID: 34665400.
Copy Download .nbib Format: NLM
Urinary beta-2 microglobulin as an early predictive biomarker of acute kidney injury in neonates with perinatal asphyxia.

European journal of pediatrics

Abdullah, Kadam P, Yachha M, Srivastava G, Pillai A, Pandita A.
PMID: 34279716
Eur J Pediatr. 2022 Jan;181(1):281-286. doi: 10.1007/s00431-021-04205-w. Epub 2021 Jul 19.

To evaluate the role of urinary beta-2 microglobulin (B2mG) as an early predictive biomarker of acute kidney injury (AKI) in neonates with perinatal asphyxia. In this prospective cohort study, 80 term infants with perinatal asphyxia were included. The neonates...

Cite
Abdullah, Kadam P, Yachha M, et al. Urinary beta-2 microglobulin as an early predictive biomarker of acute kidney injury in neonates with perinatal asphyxia. Eur J Pediatr. 2021;181(1):281-286doi: 10.1007/s00431-021-04205-w.
Abdullah, Kadam, P., Yachha, M., Srivastava, G., Pillai, A., & Pandita, A. (2022). Urinary beta-2 microglobulin as an early predictive biomarker of acute kidney injury in neonates with perinatal asphyxia. European journal of pediatrics, 181(1), 281-286. https://doi.org/10.1007/s00431-021-04205-w
Abdullah, et al. "Urinary beta-2 microglobulin as an early predictive biomarker of acute kidney injury in neonates with perinatal asphyxia." European journal of pediatrics vol. 181,1 (2022): 281-286. doi: https://doi.org/10.1007/s00431-021-04205-w
Abdullah, Kadam P, Yachha M, Srivastava G, Pillai A, Pandita A. Urinary beta-2 microglobulin as an early predictive biomarker of acute kidney injury in neonates with perinatal asphyxia. Eur J Pediatr. 2022 Jan;181(1):281-286. doi: 10.1007/s00431-021-04205-w. Epub 2021 Jul 19. PMID: 34279716.
Copy Download .nbib Format: NLM
Comparative efficacy between hemodialysis using super high-flux dialyzer with hemoperfusion and high-volume postdilution online hemodiafiltration in removing protein bound and middle molecule uremic toxins: A cross-over randomized controlled trial.

Artificial organs

Tiranathanagul K, Khemnark N, Takkavatakarn K, Limjariyakul M, Mahatanan N, Chariyavilaskul P, Wittayalertpanya S, Susantitaphong P, Eiam-Ong S.
PMID: 35028951
Artif Organs. 2022 Jan 14; doi: 10.1111/aor.14161. Epub 2022 Jan 14.

BACKGROUND: Hemodialysis (HD) using super high-flux dialyzer (HD + SHF) comparably removed uremic toxins to high-volume postdilution online hemodiafiltration (olHDF). Integration of hemoperfusion (HP) to HD + SHF (HD + SHF + HP) might provide superior uremic toxin removing...

Cite
Tiranathanagul K, Khemnark N, Takkavatakarn K, et al. Comparative efficacy between hemodialysis using super high-flux dialyzer with hemoperfusion and high-volume postdilution online hemodiafiltration in removing protein bound and middle molecule uremic toxins: A cross-over randomized controlled trial. Artif Organs. 2022;doi: 10.1111/aor.14161.
Tiranathanagul, K., Khemnark, N., Takkavatakarn, K., Limjariyakul, M., Mahatanan, N., Chariyavilaskul, P., Wittayalertpanya, S., Susantitaphong, P., & Eiam-Ong, S. (2022). Comparative efficacy between hemodialysis using super high-flux dialyzer with hemoperfusion and high-volume postdilution online hemodiafiltration in removing protein bound and middle molecule uremic toxins: A cross-over randomized controlled trial. Artificial organs, . https://doi.org/10.1111/aor.14161
Tiranathanagul, Khajohn, et al. "Comparative efficacy between hemodialysis using super high-flux dialyzer with hemoperfusion and high-volume postdilution online hemodiafiltration in removing protein bound and middle molecule uremic toxins: A cross-over randomized controlled trial." Artificial organs vol. (2022). doi: https://doi.org/10.1111/aor.14161
Tiranathanagul K, Khemnark N, Takkavatakarn K, Limjariyakul M, Mahatanan N, Chariyavilaskul P, Wittayalertpanya S, Susantitaphong P, Eiam-Ong S. Comparative efficacy between hemodialysis using super high-flux dialyzer with hemoperfusion and high-volume postdilution online hemodiafiltration in removing protein bound and middle molecule uremic toxins: A cross-over randomized controlled trial. Artif Organs. 2022 Jan 14; doi: 10.1111/aor.14161. Epub 2022 Jan 14. PMID: 35028951.
Copy Download .nbib Format: NLM
Biomarkers of B cell activation in autoimmune connective tissue diseases: More than markers of disease activity.

Clinical biochemistry

Du AX, Gniadecki R, Osman M.
PMID: 34822848
Clin Biochem. 2021 Nov 22; doi: 10.1016/j.clinbiochem.2021.11.009. Epub 2021 Nov 22.

B cells play a central role in the pathogenesis of many autoimmune diseases, acting as antigen-presenting cells, producing inflammatory cytokines, and acting as a source of autoantibodies after differentiating into plasma cells. In this review, we aim to summarize...

Cite
Du AX, Gniadecki R, Osman M. Biomarkers of B cell activation in autoimmune connective tissue diseases: More than markers of disease activity. Clin Biochem. 2021;doi: 10.1016/j.clinbiochem.2021.11.009.
Du, A. X., Gniadecki, R., & Osman, M. (2021). Biomarkers of B cell activation in autoimmune connective tissue diseases: More than markers of disease activity. Clinical biochemistry, . https://doi.org/10.1016/j.clinbiochem.2021.11.009
Du, Amy X, et al. "Biomarkers of B cell activation in autoimmune connective tissue diseases: More than markers of disease activity." Clinical biochemistry vol. (2021). doi: https://doi.org/10.1016/j.clinbiochem.2021.11.009
Du AX, Gniadecki R, Osman M. Biomarkers of B cell activation in autoimmune connective tissue diseases: More than markers of disease activity. Clin Biochem. 2021 Nov 22; doi: 10.1016/j.clinbiochem.2021.11.009. Epub 2021 Nov 22. PMID: 34822848.
Copy Download .nbib Format: NLM
Identification and evaluation of an appropriate housekeeping gene for real time gene profiling of hepatocellular carcinoma cells cultured in three dimensional scaffold.

Molecular biology reports

Badekila AK, Rai P, Kini S.
PMID: 34665400
Mol Biol Rep. 2022 Jan;49(1):797-804. doi: 10.1007/s11033-021-06830-y. Epub 2021 Oct 19.

BACKGROUND: Assessing an optimal reference gene as an internal control for target gene normalization is important during quantitative real time polymerase chain reaction (RT-qPCR) of three dimensional (3D) cell culture. Especially, gene profiling of cancer cells under a complex...

Cite
Badekila AK, Rai P, Kini S. Identification and evaluation of an appropriate housekeeping gene for real time gene profiling of hepatocellular carcinoma cells cultured in three dimensional scaffold. Mol Biol Rep. 2021;49(1):797-804doi: 10.1007/s11033-021-06830-y.
Badekila, A. K., Rai, P., & Kini, S. (2022). Identification and evaluation of an appropriate housekeeping gene for real time gene profiling of hepatocellular carcinoma cells cultured in three dimensional scaffold. Molecular biology reports, 49(1), 797-804. https://doi.org/10.1007/s11033-021-06830-y
Badekila, Anjana Kaveri, et al. "Identification and evaluation of an appropriate housekeeping gene for real time gene profiling of hepatocellular carcinoma cells cultured in three dimensional scaffold." Molecular biology reports vol. 49,1 (2022): 797-804. doi: https://doi.org/10.1007/s11033-021-06830-y
Badekila AK, Rai P, Kini S. Identification and evaluation of an appropriate housekeeping gene for real time gene profiling of hepatocellular carcinoma cells cultured in three dimensional scaffold. Mol Biol Rep. 2022 Jan;49(1):797-804. doi: 10.1007/s11033-021-06830-y. Epub 2021 Oct 19. PMID: 34665400.
Copy Download .nbib Format: NLM
Validation of POD24 As a Robust Early Clinical Endpoint of Poor Survival in FL from 5,225 Patients on 13 Clinical Trials.

Blood

Casulo C, Dixon JG, Le-Rademacher J, Hoster E, Hochster H, Hiddemann W, Marcus RE, Kimby EK, Herold M, Sebban CJ, Gyan E, Foon KA, Nielsen TG, Vitolo U, Salles GA, Shi Q, Flowers CR.
PMID: 34614146
Blood. 2021 Oct 06; doi: 10.1182/blood.2020010263. Epub 2021 Oct 06.

Observational studies and standalone trials indicate that patients with follicular lymphoma (FL) who experience disease progression within 24 months of front-line chemoimmunotherapy (POD24), have poor outcomes. We performed a pooled analysis of 13 randomized clinical trials of FL patients...

Cite
Casulo C, Dixon JG, Le-Rademacher J, et al. Validation of POD24 As a Robust Early Clinical Endpoint of Poor Survival in FL from 5,225 Patients on 13 Clinical Trials. Blood. 2021;doi: 10.1182/blood.2020010263.
Casulo, C., Dixon, J. G., Le-Rademacher, J., Hoster, E., Hochster, H., Hiddemann, W., Marcus, R. E., Kimby, E. K., Herold, M., Sebban, C. J., Gyan, E., Foon, K. A., Nielsen, T. G., Vitolo, U., Salles, G. A., Shi, Q., & Flowers, C. R. (2021). Validation of POD24 As a Robust Early Clinical Endpoint of Poor Survival in FL from 5,225 Patients on 13 Clinical Trials. Blood, . https://doi.org/10.1182/blood.2020010263
Casulo, Carla, et al. "Validation of POD24 As a Robust Early Clinical Endpoint of Poor Survival in FL from 5,225 Patients on 13 Clinical Trials." Blood vol. (2021). doi: https://doi.org/10.1182/blood.2020010263
Casulo C, Dixon JG, Le-Rademacher J, Hoster E, Hochster H, Hiddemann W, Marcus RE, Kimby EK, Herold M, Sebban CJ, Gyan E, Foon KA, Nielsen TG, Vitolo U, Salles GA, Shi Q, Flowers CR. Validation of POD24 As a Robust Early Clinical Endpoint of Poor Survival in FL from 5,225 Patients on 13 Clinical Trials. Blood. 2021 Oct 06; doi: 10.1182/blood.2020010263. Epub 2021 Oct 06. PMID: 34614146.
Copy Download .nbib Format: NLM
Impact of beta-2 microglobulin expression on the survival of glioma patients via modulating the tumor immune microenvironment.

CNS neuroscience & therapeutics

Tang F, Zhao YH, Zhang Q, Wei W, Tian SF, Li C, Yao J, Wang ZF, Li ZQ.
PMID: 33960680
CNS Neurosci Ther. 2021 Aug;27(8):951-962. doi: 10.1111/cns.13649. Epub 2021 May 07.

AIMS: High immune cell infiltration in gliomas establishes an immunosuppressive tumor microenvironment, which in turn promotes resistance to immunotherapy. Hence, it is important to identify novel targets associated with high immune cell infiltration in gliomas. Our previous study showed...

Cite
Tang F, Zhao YH, Zhang Q, et al. Impact of beta-2 microglobulin expression on the survival of glioma patients via modulating the tumor immune microenvironment. CNS Neurosci Ther. 2021;27(8):951-962doi: 10.1111/cns.13649.
Tang, F., Zhao, Y. H., Zhang, Q., Wei, W., Tian, S. F., Li, C., Yao, J., Wang, Z. F., & Li, Z. Q. (2021). Impact of beta-2 microglobulin expression on the survival of glioma patients via modulating the tumor immune microenvironment. CNS neuroscience & therapeutics, 27(8), 951-962. https://doi.org/10.1111/cns.13649
Tang, Feng, et al. "Impact of beta-2 microglobulin expression on the survival of glioma patients via modulating the tumor immune microenvironment." CNS neuroscience & therapeutics vol. 27,8 (2021): 951-962. doi: https://doi.org/10.1111/cns.13649
Tang F, Zhao YH, Zhang Q, Wei W, Tian SF, Li C, Yao J, Wang ZF, Li ZQ. Impact of beta-2 microglobulin expression on the survival of glioma patients via modulating the tumor immune microenvironment. CNS Neurosci Ther. 2021 Aug;27(8):951-962. doi: 10.1111/cns.13649. Epub 2021 May 07. PMID: 33960680; PMCID: PMC8265948.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 174 entries